AAAAAA
Results:
1-13
|
Results: 13
Authors:
PERAULT MC
BERGOUGNAN L
PAILLAT A
ZIELENIUK I
ROSENZWEIG P
VANDEL B
Citation: Mc. Perault et al., LACK OF INTERACTION BETWEEN AMISULPRIDE AND LORAZEPAM ON PSYCHOMOTOR PERFORMANCE AND MEMORY IN HEALTHY-VOLUNTEERS, Human psychopharmacology, 13(7), 1998, pp. 493-500
Authors:
HAMONVILCOT B
CHAUFOUR S
DESCHAMPS C
CANAL M
ZIELENIUK I
AHTOY P
CHRETIEN P
ROSENZWEIG P
NASR A
PIETTE F
Citation: B. Hamonvilcot et al., SAFETY AND PHARMACOKINETICS OF A SINGLE ORAL DOSE OF AMISULPRIDE IN HEALTHY ELDERLY VOLUNTEERS, European Journal of Clinical Pharmacology, 54(5), 1998, pp. 405-409
Authors:
ROSENZWEIG P
PATAT A
ZIELENIUK I
CIMAROSTI I
ALLAIN H
GANDON JM
Citation: P. Rosenzweig et al., COGNITIVE PERFORMANCE IN ELDERLY SUBJECTS AFTER A SINGLE-DOSE OF BEFLOXATONE, A NEW REVERSIBLE SELECTIVE MONOAMINE-OXIDASE-A INHIBITOR, Clinical pharmacology and therapeutics, 64(2), 1998, pp. 211-222
Authors:
ROSENZWEIG P
COLLE M
BIANCHETTI G
ZIELENIUK I
Citation: P. Rosenzweig et al., NOCTURNAL HORMONAL PROFILES AFTER ZOLPIDEM IN HEALTHY MALE-VOLUNTEERS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 59-59
Authors:
PINQUIER JL
CAPLAIN H
DURRIEU G
ZIELENIUK I
ROSENZWEIG P
Citation: Jl. Pinquier et al., SAFETY AND PHARMACODYNAMIC STUDY OF BEFLOXATONE (B) AFTER FLUOXETINE (F) WITHDRAWAL, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 60-60
Authors:
ROSENZWEIG P
LANGLEY S
JENSEN R
BROHIER S
ZIELENIUK I
Citation: P. Rosenzweig et al., A NEW METHOD ASSESSING DEPRESSANT EFFECT OF DRUGS ON RESPIRATORY DRIVE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 43-43
Authors:
PATAT A
LECOZ F
DUBRUC C
GANDON JM
DURRIEU G
CIMAROSTI I
JEZEQUEL S
CURET O
ZIELENIUK I
ALLAIN H
ROSENZWEIG P
Citation: A. Patat et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF 2 DOSE REGIMENS OF BEFLOXATONE, A NEW REVERSIBLE AND SELECTIVE MONOAMINE-OXIDASE INHIBITOR, AT STEADY-STATE IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(3), 1996, pp. 216-229
Authors:
WAROT D
BERLIN I
PATAT A
DURRIEU G
ZIELENIUK I
PUECH AJ
Citation: D. Warot et al., EFFECTS OF BEFLOXATONE, A REVERSIBLE SELECTIVE MONOAMINE-OXIDASE A INHIBITOR, ON PSYCHOMOTOR FUNCTION AND MEMORY IN HEALTHY-SUBJECTS, Journal of clinical pharmacology, 36(10), 1996, pp. 942-950
Authors:
PATAT A
PERAULT MC
VANDEL B
ULLIAC N
ZIELENIUK I
ROSENZWEIG P
Citation: A. Patat et al., LACK OF INTERACTION BETWEEN A NEW ANTIHISTAMINE, MIZOLASTINE, AND LORAZEPAM ON PSYCHOMOTOR PERFORMANCE AND MEMORY IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 39(1), 1995, pp. 31-38
Authors:
PATAT A
PERAULT MC
VANDEL B
DANJOU P
BROHIER S
ZIELENIUK I
ROSENZWEIG P
Citation: A. Patat et al., ASSESSMENT OF THE INTERACTION BETWEEN A PARTIAL AGONIST AND A FULL AGONIST OF BENZODIAZEPINE RECEPTORS, BASED ON PSYCHOMOTOR PERFORMANCE AND MEMORY, IN HEALTHY-VOLUNTEERS, J PSYCHOPH, 9(2), 1995, pp. 91-101
Authors:
PATAT A
STUBBS D
DUNMORE C
ULLIAC N
SEXTON B
ZIELENIUK I
IRVING A
JONES W
Citation: A. Patat et al., LACK OF INTERACTION BETWEEN 2 ANTIHISTAMINES, MIZOLASTINE AND CETIRIZINE, AND ETHANOL IN PSYCHOMOTOR AND DRIVING PERFORMANCE IN HEALTHY-SUBJECTS, European Journal of Clinical Pharmacology, 48(2), 1995, pp. 143-150
Authors:
PATAT A
MOLINIER P
HERGUETA T
BROHIER S
ZIELENIUK I
DANJOU P
WAROT D
PUECH A
Citation: A. Patat et al., LACK OF AMNESTIC, PSYCHOTOMIMETIC OR IMPAIRING EFFECT ON PSYCHOMOTOR PERFORMANCE OF ELIPRODIL, A NEW NMDA ANTAGONIST, International clinical psychopharmacology, 9(3), 1994, pp. 155-162
Authors:
PATAT A
PERRAULT MC
VANDEL B
ZIELENIUK I
BROHIER S
MORSELLI PL
ROSENZWEIG P
Citation: A. Patat et al., PHARMACODYNAMIC INTERACTION BETWEEN ALPIDEM AND LORAZEPAM, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 134-134
Risultati:
1-13
|